Unknown

Dataset Information

0

Glycines from the APP GXXXG/GXXXA Transmembrane Motifs Promote Formation of Pathogenic A? Oligomers in Cells.


ABSTRACT: Alzheimer's disease (AD) is the most common neurodegenerative disorder characterized by progressive cognitive decline leading to dementia. The amyloid precursor protein (APP) is a ubiquitous type I transmembrane (TM) protein sequentially processed to generate the ?-amyloid peptide (A?), the major constituent of senile plaques that are typical AD lesions. There is a growing body of evidence that soluble A? oligomers correlate with clinical symptoms associated with the disease. The A? sequence begins in the extracellular juxtamembrane region of APP and includes roughly half of the TM domain. This region contains GXXXG and GXXXA motifs, which are critical for both TM protein interactions and fibrillogenic properties of peptides derived from TM ?-helices. Glycine-to-leucine mutations of these motifs were previously shown to affect APP processing and A? production in cells. However, the detailed contribution of these motifs to APP dimerization, their relation to processing, and the conformational changes they can induce within A? species remains undefined. Here, we describe highly resistant A?42 oligomers that are produced in cellular membrane compartments. They are formed in cells by processing of the APP amyloidogenic C-terminal fragment (C99), or by direct expression of a peptide corresponding to A?42, but not to A?40. By a point-mutation approach, we demonstrate that glycine-to-leucine mutations in the G(29)XXXG(33) and G(38)XXXA(42) motifs dramatically affect the A? oligomerization process. G33 and G38 in these motifs are specifically involved in A? oligomerization; the G33L mutation strongly promotes oligomerization, while G38L blocks it with a dominant effect on G33 residue modification. Finally, we report that the secreted A?42 oligomers display pathological properties consistent with their suggested role in AD, but do not induce toxicity in survival assays with neuronal cells. Exposure of neurons to these A?42 oligomers dramatically affects neuronal differentiation and, consequently, neuronal network maturation.

SUBMITTER: Decock M 

PROVIDER: S-EPMC4861705 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Glycines from the APP GXXXG/GXXXA Transmembrane Motifs Promote Formation of Pathogenic Aβ Oligomers in Cells.

Decock Marie M   Stanga Serena S   Octave Jean-Noël JN   Dewachter Ilse I   Smith Steven O SO   Constantinescu Stefan N SN   Kienlen-Campard Pascal P  

Frontiers in aging neuroscience 20160510


Alzheimer's disease (AD) is the most common neurodegenerative disorder characterized by progressive cognitive decline leading to dementia. The amyloid precursor protein (APP) is a ubiquitous type I transmembrane (TM) protein sequentially processed to generate the β-amyloid peptide (Aβ), the major constituent of senile plaques that are typical AD lesions. There is a growing body of evidence that soluble Aβ oligomers correlate with clinical symptoms associated with the disease. The Aβ sequence beg  ...[more]

Similar Datasets

| S-EPMC2702479 | biostudies-literature
| S-EPMC7961089 | biostudies-literature
| S-EPMC3536380 | biostudies-literature
| S-EPMC3192960 | biostudies-literature
| S-EPMC1829382 | biostudies-literature
| S-EPMC10320510 | biostudies-literature
| S-EPMC5529106 | biostudies-literature
| S-EPMC8324842 | biostudies-literature
| S-EPMC6916291 | biostudies-literature
| S-EPMC6554322 | biostudies-literature